WHOOP Raises $575M Series G at $10.1B Valuation, Eyes IPO

WHOOP has raised $575 million in a Series G funding round, valuing the company at $10.1 billion. The round, closed on March 31, 2026, marks a significant increase from its $3.6 billion valuation in 2021 and is expected to be the company’s final private raise ahead of a planned IPO.

Founded in 2012, WHOOP offers a screenless wearable device that tracks strain, recovery, and sleep, delivering personalised health insights through a subscription-based app. The company has expanded beyond fitness tracking into broader health monitoring, including medical-grade features and diagnostic services.

The round was led by Collaborative Fund and includes investors such as Mubadala Investment Company, Qatar Investment Authority, Abbott, and Mayo Clinic, alongside a group of high-profile athletes and celebrities. WHOOP reports over 2.5 million members and exited 2025 with a $1.1 billion bookings run rate, achieving operating cash flow positivity during the year.

Recent product developments include the launch of WHOOP 5.0 and WHOOP MG, which incorporates FDA-cleared ECG capabilities and blood pressure insights. The company has also introduced Advanced Labs, a service combining wearable data with blood testing across a panel of biomarkers. Proceeds from the funding will support international expansion, product development, and hiring as WHOOP scales its health platform globally.